Is OMER Worth Buying in 2026?

Omeros Corporation

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-14

Here’s whether Omeros Corporation (OMER) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: strong 1-year return of +146.1%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-0.95% over 10 days); RSI 18 — oversold; 3-month momentum negative (-21.6%); rising volume on a downtrend (distribution, 1.20x avg). Currently 50.5% off its 52-week high. Score: -5/7.

Ready to act on this? 📈 Trade on Webull

OMER is trading below its 200-day MA ($10.00) — a key warning sign the longer-term trend is under pressure. An RSI of 18.1 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +146.1% compares to +22.9% for SPY (beat the market by 123.2%). The current 50.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $24,606 today
vs. S&P 500 (SPY) — same period beat market by 123.2%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($10.00)
Above 50-day MA ($12.33)
!RSI(14) neutral zone (30–70) — currently 18.1
Positive return (+146.1%)
!Within 10% of period high (−50.5%)
Period Range $8.74
$2.95 $17.65
RSI (14) 18.1
0 · OversoldOverbought · 100

Key Metrics

Price$8.74
Period Return+146.1%
Period High$17.65
Period Low$2.95
Drawdown−50.5%
MA-50$12.33
MA-200$10.00
RSI (14)18.1
Avg Volume (30d)1.8M
vs. SPYbeat by 123.2%
Return Rank#138 of 1246

Trade OMER

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers